+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Biogen Inc. - logo

Founded in 1978 Biogen Inc is a global biotechnology company with its headquarters in Cambridge, Massachusetts. In 2003 Biogen merged with Idec Pharmaceuticals to create Biogen Idec and acquired Syntonix Pharmaceuticals in 2007. In 2015 the company returned to its original name Biogen Inc and acquired Convergence Pharmaceuticals. Biogen focuses on drug discovery for a range of conditions including neuropathic pain, hemophilia, organ failure, neuromuscular disorders and oncology. Their product portfolio includes Rituxan, Avonex, Tecfidera and Eloctate.

Regenerative Medicine Market - Forecasts from 2023 to 2028 - Product Thumbnail Image

Regenerative Medicine Market - Forecasts from 2023 to 2028

  • Report
  • December 2023
  • 139 Pages
  • Global
From
From
From
Oligonucleotide Synthesis Market 2025-2029 - Product Thumbnail Image

Oligonucleotide Synthesis Market 2025-2029

  • Report
  • January 2025
  • 220 Pages
  • Global
From
From
From
From
From
From
Biosimilars Market Report and Forecast 2023-2031 - Product Thumbnail Image

Biosimilars Market Report and Forecast 2023-2031

  • Report
  • April 2023
  • 147 Pages
  • Global
From
From
From
Neurologic Disorders Therapeutics Market 2024-2028 - Product Thumbnail Image

Neurologic Disorders Therapeutics Market 2024-2028

  • Report
  • July 2024
  • 150 Pages
  • Global
From
Orphan Drugs - Global Strategic Business Report - Product Thumbnail Image

Orphan Drugs - Global Strategic Business Report

  • Report
  • July 2025
  • 409 Pages
  • Global
From
Loading Indicator